Sixty senators today urged the Centers for Medicare & Medicaid Services to delay the April 21 release of the overall hospital quality star ratings in order “to provide the necessary time to more closely examine the star rating methodology, analyze its impact on different types of hospitals, and provide more transparent information regarding the calculation of the ratings to determine accuracy.” The senators wrote, “While we support the public reporting of provider quality data, we are concerned that the current Star Ratings system may not accurately take into account hospitals that treat patients with low socioeconomic status or multiple complex chronic conditions. We appreciate CMS’s recognition in previous rulemaking of the effects these patient populations have on Medicare Advantage and Part D plans and urge CMS to give similar consideration to the similar effects on the Hospital Compare Star Ratings system.” The letter was spearheaded by Sens. Rob Portman (R-OH) and Bob Casey (D-PA). Reps. Jim Renacci (R- OH) and Bill Pascrell (D-NJ) are collecting signatures through Wednesday for a similar letter in the House.

Related News Articles

Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…
Headline
The AHA’s social media toolkit for spreading awareness of the flu focuses on the beginning of fall and the availability of the flu vaccine for at-risk,…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Centers for Disease Control and Prevention Sept. 24 released its annual report on national sexually transmitted disease data, reporting a 9% decline in STD…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…